These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16705561)

  • 1. [Decisions in case of "problematic" cost-effectiveness ratios based on the example of a clinical trial in rehabilitation care].
    Leidl R; Jacobi E; Knab J; Schweikert B
    Gesundheitswesen; 2006 Apr; 68(4):249-56. PubMed ID: 16705561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.
    Whitehurst DG; Lewis M; Yao GL; Bryan S; Raftery JP; Mullis R; Hay EM
    Arthritis Rheum; 2007 Apr; 57(3):466-73. PubMed ID: 17394176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and effects in lumbar spinal fusion. A follow-up study in 136 consecutive patients with chronic low back pain.
    Soegaard R; Christensen FB; Christiansen T; Bünger C
    Eur Spine J; 2007 May; 16(5):657-68. PubMed ID: 16871387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More is not always better: cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain.
    Smeets RJ; Severens JL; Beelen S; Vlaeyen JW; Knottnerus JA
    Eur J Pain; 2009 Jan; 13(1):71-81. PubMed ID: 18434221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of acupuncture treatment in patients with chronic neck pain.
    Willich SN; Reinhold T; Selim D; Jena S; Brinkhaus B; Witt CM
    Pain; 2006 Nov; 125(1-2):107-13. PubMed ID: 16842918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental cost effectiveness evaluation in clinical research.
    Krummenauer F; Landwehr I
    Eur J Med Res; 2005 Jan; 10(1):18-22. PubMed ID: 15737949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellners Y
    Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation.
    Critchley DJ; Ratcliffe J; Noonan S; Jones RH; Hurley MV
    Spine (Phila Pa 1976); 2007 Jun; 32(14):1474-81. PubMed ID: 17572614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumferential fusion is dominant over posterolateral fusion in a long-term perspective: cost-utility evaluation of a randomized controlled trial in severe, chronic low back pain.
    Soegaard R; Bünger CE; Christiansen T; Høy K; Eiskjaer SP; Christensen FB
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2405-14. PubMed ID: 18090078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Goal-oriented outcome measurement in inpatient or day care orthopedic-rheumatologic rehabilitation of patients with back pain].
    Merkesdal S; Bernitt K; Busche T; Bauer J; Mau W
    Rehabilitation (Stuttg); 1999 Aug; 38 Suppl 1():S37-43. PubMed ID: 10507100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial).
    Manca A; Kumar K; Taylor RS; Jacques L; Eldabe S; Meglio M; Molet J; Thomson S; O'Callaghan J; Eisenberg E; Milbouw G; Buchser E; Fortini G; Richardson J; Taylor RJ; Goeree R; Sculpher MJ
    Eur J Pain; 2008 Nov; 12(8):1047-58. PubMed ID: 18359255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is time for physicians to embrace cost-effectiveness and cost utility analysis research in the treatment of spinal pain.
    Dagenais S; Haldeman S; Polatin PB
    Spine J; 2005; 5(4):357-60. PubMed ID: 15996604
    [No Abstract]   [Full Text] [Related]  

  • 17. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
    Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
    Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
    Manca A; Dumville JC; Torgerson DJ; Klaber Moffett JA; Mooney MP; Jackson DA; Eaton S
    Rheumatology (Oxford); 2007 Sep; 46(9):1495-501. PubMed ID: 17711873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.